Jin Medical International Ltd. (NASDAQ:ZJYL - Get Free Report) saw a significant decline in short interest in September. As of September 15th, there was short interest totaling 114,600 shares, a decline of 40.1% from the August 31st total of 191,300 shares. Currently, 0.3% of the shares of the stock are sold short. Based on an average daily volume of 269,100 shares, the days-to-cover ratio is currently 0.4 days. Based on an average daily volume of 269,100 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.3% of the shares of the stock are sold short.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reissued a "hold (c-)" rating on shares of Jin Medical International in a report on Saturday, September 27th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has a consensus rating of "Hold".
Get Our Latest Report on Jin Medical International
Jin Medical International Price Performance
NASDAQ:ZJYL opened at $0.59 on Friday. Jin Medical International has a 1 year low of $0.50 and a 1 year high of $2.91. The stock has a 50-day moving average price of $0.64 and a two-hundred day moving average price of $0.70.
Jin Medical International Company Profile
(
Get Free Report)
Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Jin Medical International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jin Medical International wasn't on the list.
While Jin Medical International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.